Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

A cancer patient's eyelashes grew excessively without other common side effects after taking the cancer drug erlotinib.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Ruxolitinib treatment may cause eyelash growth.

Sunlight exposure improved a patient's skin condition, and there may be a link between a certain disease and skin growths; a leukemia treatment caused changes in hair color and growth.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Dermoscopy helps diagnose unusual skin lesions like osteonevus of Nanta and can prevent misdiagnosis of serious conditions.

Retinol may affect immune responses in people with frequent skin boils.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

TNF-alpha inhibitors can cause various immune-related skin issues.

Apremilast shows promise for several skin conditions but needs more research.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Hair loss in three Southeast Asian women with kidney failure may be linked to their anemia treatment with erythropoietin.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

Freezing gamma-irradiated amniotic fluid may help hair growth and speed up the growth phase.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Dogs with dermatomyositis, especially Collies and Shetland Sheepdogs, need better treatments for their skin and muscle inflammation.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Men with both baldness and scalp psoriasis often don't have psoriasis on bald spots.

Hair and nail conditions can stabilize or improve over time, and new treatments show promise.

The document reports unique growth lines in a child after Stevens-Johnson syndrome, skin reaction from parsnips and sun in a girl, and itchy skin with xanthomas in a boy with Alagille syndrome.

Stem cell-derived conditioned medium shows promise for treating various medical conditions but requires standardized production and further validation.